That she is speaking at all at a conference is a big change from the quiet period. She has not been speaking at conferences generally. At small events only with particular types of doctors and at luncheon presentations and generally about issues related to DCVax, whether about the phase 3 or about the combination trial….
Market Data 
Markets 
AI
